 This study found that coenzyme Q10, Coke 10, had a positive effect on reducing levels of seroactive protein, CRP, which is an indicator of inflammation in patients with end-stage renal disease, ESRD. Coke 10 may also have beneficial effects on albumin levels, which is another important marker of kidney function. Additionally, Coke 10 has been shown to reduce homocysteine levels, which is associated with increased risk of heart disease. Overall, these results suggest that Coke 10 may be beneficial in reducing inflammation and improving kidney health in patients with ESRD. This article was authored by Nargesadad Zahid, Miriam Gassamy, and Hajar Nickbecht.